Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fallopian Tube Neoplasms × sapanisertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Recurrent Malignant Solid Neoplasm 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Malignant Neoplasms of Digestive Organs 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Liver Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 67 Paclitaxel 58 Bevacizumab 35 pembrolizumab 18 Taxes 18 Cyclophosphamide 18 Gemcitabine 17 Cisplatin 17 Topotecan 14 Hyperthermic Intraperitoneal Chemotherapy 12 Immunoglobulin G 11 Disulfides 11 olaparib 10 liposomal doxorubicin 10 Specimen Handling 10 niraparib 9 Drug Therapy 9 Cytoreduction Surgical Procedures 9 Magnetic Resonance Spectroscopy 8 sargramostim 7 Surveys and Questionnaires 7 durvalumab 6 Platinum 6 Letrozole 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 Docetaxel 6 Biopsy 6 Albumin-Bound Paclitaxel 6 fludarabine 5 aldesleukin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03648489 2024-09-20

DICE

Imperial College London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡